Tonghua Dongbao Pharmaceutical Co., Ltd. 600867.SS Stock
Tonghua Dongbao Pharmaceutical Co., Ltd. Price Chart
Tonghua Dongbao Pharmaceutical Co., Ltd. 600867.SS Financial and Trading Overview
Contents
- Tonghua Dongbao Pharmaceutical Co., Ltd. Price Chart
- Tonghua Dongbao Pharmaceutical Co., Ltd. 600867.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Tonghua Dongbao Pharmaceutical Co., Ltd.
- Q&A For Tonghua Dongbao Pharmaceutical Co., Ltd. Stock
Tonghua Dongbao Pharmaceutical Co., Ltd. stock price | 10.14 CNY |
Previous Close | 10.36 CNY |
Open | 10.37 CNY |
Bid | 10.27 CNY x 0 |
Ask | 10.28 CNY x 0 |
Day's Range | 10.15 - 10.4 CNY |
52 Week Range | 8.35 - 12.49 CNY |
Volume | 15.28M CNY |
Avg. Volume | 19.18M CNY |
Market Cap | 20.5B CNY |
Beta (5Y Monthly) | 0.276027 |
PE Ratio (TTM) | 20.156862 |
EPS (TTM) | 0.59 CNY |
Forward Dividend & Yield | 0.5 (4.86%) |
Ex-Dividend Date | June 9, 2023 |
1y Target Est | 13.67 CNY |
600867.SS Valuation Measures
Enterprise Value | 19.66B CNY |
Trailing P/E | 20.156862 |
Forward P/E | 15.575757 |
PEG Ratio (5 yr expected) | -1.97 |
Price/Sales (ttm) | 8.017354 |
Price/Book (mrq) | 3.0023363 |
Enterprise Value/Revenue | 7.691 |
Enterprise Value/EBITDA | 22.854 |
Trading Information
Tonghua Dongbao Pharmaceutical Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.276027 |
52-Week Change | 1.07% |
S&P500 52-Week Change | 20.43% |
52 Week High | 12.49 CNY |
52 Week Low | 8.35 CNY |
50-Day Moving Average | 11.55 CNY |
200-Day Moving Average | 10.19 CNY |
600867.SS Share Statistics
Avg. Volume (3 month) | 19.18M CNY |
Avg. Daily Volume (10-Days) | 20.89M CNY |
Shares Outstanding | 1.99B |
Float | 1.18B |
Short Ratio | N/A |
% Held by Insiders | 42.61% |
% Held by Institutions | 7.04% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.5 |
Trailing Annual Dividend Yield | 4.82% |
5 Year Average Dividend Yield | 212.00% |
Payout Ratio | 1.0784 |
Last Split Factor | 1.2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 39.16% |
Operating Margin (ttm) | 27.72% |
Gross Margin | 75.48% |
EBITDA Margin | 33.65% |
Management Effectiveness
Return on Assets (ttm) | 6.19% |
Return on Equity (ttm) | 14.51% |
Income Statement
Revenue (ttm) | 2.56B CNY |
Revenue Per Share (ttm) | 1.29 CNY |
Quarterly Revenue Growth (yoy) | -25.00000000000000000000000000000000% |
Gross Profit (ttm) | 2.15B CNY |
EBITDA | 860.34M CNY |
Net Income Avi to Common (ttm) | 1B CNY |
Diluted EPS (ttm) | 0.51 |
Quarterly Earnings Growth (yoy) | -69.89% |
Balance Sheet
Total Cash (mrq) | 894.22M CNY |
Total Cash Per Share (mrq) | 0.45 CNY |
Total Debt (mrq) | 0 CNY |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 13.558 |
Book Value Per Share (mrq) | 3.424 |
Cash Flow Statement
Operating Cash Flow (ttm) | 665.85M CNY |
Levered Free Cash Flow (ttm) | 11.52M CNY |
Profile of Tonghua Dongbao Pharmaceutical Co., Ltd.
Country | China |
State | N/A |
City | Tonghua |
Address | Dongbao New Village |
ZIP | 134123 |
Phone | 86 43 5508 8025 |
Website | https://www.thdb.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 3054 |
Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China. The company operates through Pharmaceutical Industry; Building Materials Industry; and Real Estate Industry segments. It offers human insulin raw materials and injection, insulin glargine raw materials and injection, insulin aspart API and injection, Zhennaoning capsules, and diabetes-related medical devices. Further, it provides insulin pen and needle injection system, blood sugar monitoring system, and online and offline patient management system. It offers building materials.Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.
Q&A For Tonghua Dongbao Pharmaceutical Co., Ltd. Stock
What is a current 600867.SS stock price?
Tonghua Dongbao Pharmaceutical Co., Ltd. 600867.SS stock price today per share is 10.14 CNY.
How to purchase Tonghua Dongbao Pharmaceutical Co., Ltd. stock?
You can buy 600867.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tonghua Dongbao Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Tonghua Dongbao Pharmaceutical Co., Ltd. is 600867.SS.
Which industry does the Tonghua Dongbao Pharmaceutical Co., Ltd. company belong to?
The Tonghua Dongbao Pharmaceutical Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Tonghua Dongbao Pharmaceutical Co., Ltd. have in circulation?
The max supply of Tonghua Dongbao Pharmaceutical Co., Ltd. shares is 1.99B.
What is Tonghua Dongbao Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Tonghua Dongbao Pharmaceutical Co., Ltd. PE Ratio is 17.18644100 now.
What was Tonghua Dongbao Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Tonghua Dongbao Pharmaceutical Co., Ltd. EPS is 0.59 CNY over the trailing 12 months.
Which sector does the Tonghua Dongbao Pharmaceutical Co., Ltd. company belong to?
The Tonghua Dongbao Pharmaceutical Co., Ltd. sector is Healthcare.